Xiamen Cardiovascular Hospital Announces $460K Licensing Deal for Six Health Monitoring IP Assets

Recently, Xiamen University Affiliated Cardiovascular Hospital released a public notice on the transformation of scientific and technological achievements, proposing to transfer the relevant technologies through licensing and collaborative development.“A Multi-Device Collaborative Rehabilitation Assessment System and Method”the commercialization of six intellectual property rights, with a total transaction value of RMB3.32 million yuan. According to the public notice, the inventor of this patented technology isChen Yuan and her team, after the agreement is reached, the R&D team will work with the licenseeXiamen Fuhui Kang Electronic Technology Co., Ltd.Continue collaborative development.

This technology package integrates three core technical systems—sleep monitoring, disease risk prediction, and rehabilitation assessment. Centered on multi-device collaboration and multimodal time-series signal analysis, it enables non-invasive health monitoring and intelligent assessment with early warning capabilities around the clock and across multiple scenarios.

Early Screening and 24/7 Monitoring of Chronic Diseases Such as Cardiovascular DiseaseIt is a core component of health management, and abnormal changes in physiological indicators such as gait characteristics and heart rate variability serve as important early warning signals for cardiovascular diseases and neurodegenerative disorders.

In clinical practice, chronic disease screening primarily relies on intermittent static tests conducted in hospitals, while home and community settings utilize various portable monitoring devices. However, both approaches struggle to achieve continuous and comprehensive capture of dynamic physiological indicators and movement characteristics, leading to the frequent oversight of early disease risks. This has become a key challenge constraining early screening and treatment of chronic diseases, as well as the assessment of rehabilitation outcomes.

Current health monitoring needs span multiple scenarios, including chronic disease prevention, early warning of disease risks, and postoperative rehabilitation assessment. This requires capturing multidimensional data—such as gait cycles, plantar pressure, heart rate, and respiration—during daily activities, as well as constructing individualized health profiles through long-term continuous monitoring to enable precise prediction of disease risks. Although mainstream solutions in the health monitoring field include commercial portable devices for recording basic physiological indicators and clinical professional equipment for specialized tests such as gait analysis, these two approaches remain fragmented and fail to form a closed-loop data system.

More critically, existing monitoring protocols predominantly adopt a design paradigm centered on single-device, single-modality data acquisition. This approach suffers from inherent limitations: standalone wearable devices can only record basic metrics such as heart rate and step count, failing to capture gait dynamics and macroscopic movement states; meanwhile, specialized diagnostic equipment is restricted to analyzing specific indicators and cannot facilitate daily monitoring due to situational constraints. Consequently, this leads to insufficient data dimensionality and weak correlations, undermining the ability to support precise prediction of disease risks.

Meanwhile, traditional monitoring devicesLack of Effective Multi-Device Collaboration and Data Fusion Mechanisms, data collected by different devices suffer from spatiotemporal asynchronization and errors that cannot be cross-validated. For instance, inconsistencies between the acquisition clocks of plantar pressure devices and heart rate monitors undermine the basis for data fusion analysis, further diminishing the reference value of monitoring results.

Furthermore,Current monitoring protocols exhibit significant scenario fragmentation and monitoring blind spots., during the day, data collection relies on wearable devices, while at night, data interruption occurs due to comfort issues associated with wearing them. Moreover, non-contact monitoring devices are mostly limited to single sleep scenarios and cannot integrate with wearable device data, making it difficult to achieve continuous, all-day, multi-scenario monitoring and fully capture the patterns of changes in human physiological and movement metrics.

In addition,Insufficient Data Analysis Capabilities of Existing Monitoring TechnologiesMost devices are limited to data recording and lack machine learning analysis models integrated with clinical diagnostic and treatment standards. Consequently, they fail to identify the intrinsic correlations among gait patterns, physiological indicators, and disease risks, nor can they generate personalized health recommendations and risk alerts based on individual data. Even systems equipped with analytical capabilities often suffer from single-dimensional data inputs and insufficient accuracy, resulting in low reference value for alert outcomes. This makes them inadequate for meeting the practical needs of early clinical disease screening, rehabilitation assessment, and home health management.

These challenges have created an urgent need in the health monitoring sector for an intelligent monitoring system that integrates multi-dimensional data acquisition, multi-device coordination, and full-scenario adaptability, thereby addressing the industry’s current predicaments of low precision in disease early warning and discontinuous health monitoring.

Addressing core pain points in the health monitoring field, such as fragmented data, poor synchronization, weak scenario adaptability, and lack of clinical support for early warnings, the team has proposed a solution based on multi-device collaboration and multimodal fusion. This technology package, throughMulti-device collaborative acquisition, high-precision spatiotemporal synchronization calibration, and clinical-grade intelligent analysisAchieved an upgrade from basic data recording to clinically actionable disease risk alerts, with extended coverage across diverse scenarios such as rehabilitation assessment and sleep monitoring.

Data Collection Phase, the team adoptedConstruction of a Multi-Dimensional Vital Signs Acquisition System Integrating Contactless and Wearable Devices, achieving comprehensive coverage through complementary data.

Among these, millimeter-wave devices capture macroscopic movement trajectories in a non-intrusive manner while simultaneously extracting vital signs such as heart rate and respiratory frequency; plantar pressure-sensing insoles meticulously collect plantar pressure distribution during the gait cycle to calculate kinetic parameters including stride length, walking speed, and symmetry; and smart wristbands continuously monitor exercise intensity, heart rate variability (HRV), and sleep-related physiological indicators. These three types of devices form a multi-dimensional, highly redundant data complementarity system—spanning from global to local perspectives and from motion to physiology—comprehensively covering key health signals during daily activities, rest, and sleep.

Data Validation Phase, the team throughSpatiotemporal Synchronization and Cross-Validation Mechanism, ensuring clinical-grade reliability of monitoring data from the source.

The device’s central processing unit employs a high-precision timestamp synchronization algorithm to achieve accurate spatiotemporal alignment of data from multiple sources. On one hand, the device cross-validates gait onset and offset events detected by millimeter-wave radar with abrupt changes in plantar pressure, thereby dynamically calibrating gait cycle parameters. On the other hand, by integrating adaptive signal filtering techniques, the device effectively suppresses environmental noise and interference arising from individual differences, significantly reducing both systematic and random errors associated with single-device measurements.

Data Analysis Phase, teamDevelopment of an Intelligent Analysis and Precision Early Warning System Integrating Clinical Knowledge, enabling in-depth transformation of data value.

The system incorporates a risk prediction model based on machine learning technology and a cardiovascular health assessment module. It can accurately identify synergistic deviation patterns in multimodal indicators, such as gait rhythm disturbances and abnormal heart rate variability, and correlate them with high-risk conditions including cardiovascular diseases and neurodegenerative disorders, thereby enabling early risk alerts. Meanwhile, the anomaly alert module provides real-time feedback on the user’s exercise status and generates personalized health recommendations by integrating individual historical data. This framework not only meets the needs of the general population for early screening of chronic diseases but also provides professional-grade metric tracking and a basis for regimen adjustments for postoperative patients or those undergoing chronic disease rehabilitation, forming“Monitoring–Analysis–Early Warning–Guidance”closed-loop management model.

Moreover, by adopting a dual-mode monitoring strategy that combines wearable and non-contact technologies, the system achieves seamless, continuous, all-weather monitoring across multiple scenarios, effectively overcoming the spatiotemporal fragmentation bottleneck inherent in traditional solutions.

Leveraging technological innovations across all stages, the team has established a comprehensive intellectual property portfolio integrating patents and software copyrights. By adopting standardized communication protocols, the solution enables flexible integration of multi-brand devices, significantly reducing industrialization and integration costs.

As the demand for chronic disease management and health monitoring continues to escalate, the global market for multi-device collaborative health monitoring has entered a period of rapid development. Enterprises and research institutions both in China and abroad are actively positioning themselves, driving technological innovations centered on core pain points such as device interoperability, data fusion, and scenario adaptation, thereby forming“Consumer-Grade Health Device Iteration + Medical-Grade Monitoring System Implementation”competitive landscape, with public information corroborating the technical specifications and research progress of related products.

Huawei, in the field of health monitoring, withWearable DevicesCentered on this core, it has built an ecosystem comprising “smart bands/watches + the Huawei Health app + integration with third-party devices.” Its newly launched Huawei Watch GT 6 Pro features a multi-sensor fusion solution, incorporating components such as a heart rate sensor, accelerometer, and gyroscope. It can monitor basic metrics including heart rate variability, exercise trajectories, and sleep quality, and supports data interoperability with Huawei smart body fat scales, blood pressure monitors, and other devices, thereby demonstrating initial capabilities for multi-device data integration. By leveraging algorithmic models to analyze the correlation between exercise and physiological indicators, the device offers functions such as cardiovascular health risk screening and sleep apnea alerts. Suitable for daily health management scenarios, it has already achieved commercial mass production.

AppleZheng YiApple WatchTo build a health monitoring ecosystem at its core, the latest Apple Watch Series 11 features an upgraded sensor array that supports multi-dimensional data collection, including heart rate, electrocardiogram (ECG), blood oxygen saturation, activity tracking, and sleep quality. It also enables data interoperability with third-party health devices, such as glucose meters and smart scales, through the Health app. The device’s built-in “Heart Monitoring” feature can detect abnormal heart rates and assess atrial fibrillation risk, while the “Sleep Analysis” function evaluates sleep stages and changes in respiratory rate, leveraging machine learning algorithms to provide basic health risk alerts. The product is currently being mass-produced and sold globally.

Lepu MedicalAs the leading enterprise in China’s cardiovascular medical device sector, its products“Tongxin Steward Checkme Lite”An integrated chronic disease monitoring solution has been developed, combining “smart wearable devices + health management platforms + telemedicine services.” Leveraging artificial intelligence algorithms, this solution accurately identifies and analyzes up to 45 types of electrocardiogram (ECG) abnormalities. The device is compact, portable, and user-friendly. It integrates features such as AI-powered rapid analysis and early warning, human intervention, interpretation of reports by cardiology specialists, and one-on-one video consultations. Furthermore, it collaborates with over 2,000 offline hospitals to provide medical guidance. The solution is widely applied in scenarios including home-based chronic disease management, community health screening, and postoperative follow-up for cardiovascular diseases.

Overall, the current health monitoring sector is exhibiting trends toward diversification and collaboration, with different companies leveraging their respective strengths to explore distinct development paths. Consumer electronics companies are centering on wearable devices to continuously enrich the ecosystem for daily health management, while medical technology companies are delving into chronic disease management and clinical services to drive application innovation in professional medical settings. These practices collectively propel the industry toward greater precision and systematization. In the future, the industry will continue to evolve toward smarter solutions, better clinical adaptability, and more comprehensive lifecycle management, providing stronger support for both personal health and professional medical care.